-DOCSTART- -X- O
BACKGROUND -X- _ O
: -X- _ O
Household -X- _ B-Intervention
transmission -X- _ I-Intervention
of -X- _ O
influenza-like -X- _ B-Patient
illness -X- _ I-Patient
( -X- _ I-Patient
ILI -X- _ I-Patient
) -X- _ I-Patient
may -X- _ O
vary -X- _ O
with -X- _ O
viral -X- _ O
and -X- _ O
demographic -X- _ O
characteristics. -X- _ O
We -X- _ O
examined -X- _ O
the -X- _ O
effect -X- _ O
of -X- _ O
these -X- _ O
factors -X- _ O
in -X- _ O
a -X- _ O
population-based -X- _ O
sample -X- _ B-Patient
of -X- _ I-Patient
adults -X- _ I-Patient
with -X- _ I-Patient
ILI. -X- _ I-Patient
METHODS -X- _ O
: -X- _ O
We -X- _ O
conducted -X- _ O
a -X- _ O
prospective -X- _ O
cohort -X- _ O
study -X- _ O
in -X- _ O
community- -X- _ O
dwelling -X- _ O
Australian -X- _ O
adults -X- _ O
nested -X- _ O
within -X- _ O
an -X- _ O
influenza -X- _ O
vaccine -X- _ O
effectiveness -X- _ O
trial. -X- _ O
On -X- _ O
presentation -X- _ O
with -X- _ O
ILI -X- _ O
, -X- _ O
participants -X- _ O
were -X- _ O
swabbed -X- _ O
for -X- _ O
a -X- _ O
range -X- _ O
of -X- _ O
respiratory -X- _ O
viruses -X- _ O
and -X- _ O
asked -X- _ O
to -X- _ O
return -X- _ O
a -X- _ O
questionnaire -X- _ O
collecting -X- _ O
details -X- _ O
of -X- _ O
household -X- _ O
members -X- _ O
with -X- _ O
or -X- _ O
without -X- _ O
similar -X- _ O
symptoms. -X- _ O
We -X- _ O
used -X- _ O
logistic -X- _ O
and -X- _ O
Poisson -X- _ O
regression -X- _ O
to -X- _ O
assess -X- _ O
the -X- _ O
key -X- _ B-Intervention
characteristics -X- _ I-Intervention
of -X- _ I-Intervention
household -X- _ I-Intervention
transmission. -X- _ I-Intervention
RESULTS -X- _ O
: -X- _ O
258 -X- _ O
participants -X- _ O
from -X- _ O
multi-occupancy -X- _ O
households -X- _ O
experienced -X- _ O
279 -X- _ O
ILI -X- _ O
episodes -X- _ O
and -X- _ O
returned -X- _ O
a -X- _ O
questionnaire. -X- _ O
Of -X- _ O
these -X- _ O
, -X- _ O
183 -X- _ B-Patient
were -X- _ O
the -X- _ O
primary -X- _ O
case -X- _ O
in -X- _ O
the -X- _ O
household -X- _ O
allowing -X- _ O
assessment -X- _ O
of -X- _ O
factors -X- _ O
associated -X- _ O
with -X- _ O
transmission. -X- _ O
Transmission -X- _ B-Outcome
was -X- _ I-Outcome
significantly -X- _ I-Outcome
associated -X- _ I-Outcome
in -X- _ I-Outcome
univariate -X- _ I-Outcome
analyses -X- _ I-Outcome
with -X- _ I-Outcome
female -X- _ I-Outcome
sex -X- _ I-Outcome
( -X- _ I-Outcome
27 -X- _ I-Outcome
% -X- _ I-Outcome
vs. -X- _ I-Outcome
13 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
risk -X- _ I-Outcome
ratio -X- _ I-Outcome
( -X- _ I-Outcome
RR -X- _ I-Outcome
) -X- _ I-Outcome
= -X- _ I-Outcome
2.13 -X- _ I-Outcome
( -X- _ I-Outcome
1.08 -X- _ I-Outcome
, -X- _ I-Outcome
4.21 -X- _ I-Outcome
) -X- _ I-Outcome
) -X- _ I-Outcome
and -X- _ I-Outcome
the -X- _ I-Outcome
presence -X- _ I-Outcome
of -X- _ I-Outcome
a -X- _ I-Outcome
child -X- _ I-Outcome
in -X- _ I-Outcome
the -X- _ I-Outcome
house -X- _ I-Outcome
( -X- _ I-Outcome
33 -X- _ I-Outcome
% -X- _ I-Outcome
vs. -X- _ I-Outcome
17 -X- _ I-Outcome
% -X- _ I-Outcome
, -X- _ I-Outcome
RR -X- _ I-Outcome
= -X- _ I-Outcome
1.90 -X- _ I-Outcome
( -X- _ I-Outcome
1.11 -X- _ I-Outcome
, -X- _ I-Outcome
3.26 -X- _ I-Outcome
) -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
The -X- _ I-Outcome
secondary -X- _ I-Outcome
household -X- _ I-Outcome
attack -X- _ I-Outcome
proportion -X- _ I-Outcome
( -X- _ I-Outcome
SHAP -X- _ I-Outcome
) -X- _ I-Outcome
was -X- _ I-Outcome
0.14 -X- _ I-Outcome
, -X- _ I-Outcome
higher -X- _ I-Outcome
if -X- _ I-Outcome
influenza -X- _ I-Outcome
was -X- _ I-Outcome
isolated -X- _ I-Outcome
( -X- _ I-Outcome
RR -X- _ I-Outcome
= -X- _ I-Outcome
2.1 -X- _ I-Outcome
( -X- _ I-Outcome
1.0 -X- _ I-Outcome
, -X- _ I-Outcome
4.5 -X- _ I-Outcome
) -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ I-Outcome
Vaccinated -X- _ I-Outcome
participants -X- _ I-Outcome
who -X- _ I-Outcome
nonetheless -X- _ I-Outcome
became -X- _ I-Outcome
infected -X- _ I-Outcome
with -X- _ I-Outcome
influenza -X- _ I-Outcome
had -X- _ I-Outcome
a -X- _ I-Outcome
higher -X- _ I-Outcome
SHAP -X- _ I-Outcome
( -X- _ I-Outcome
Incidence -X- _ I-Outcome
RR -X- _ I-Outcome
= -X- _ I-Outcome
5.24 -X- _ I-Outcome
( -X- _ I-Outcome
2.17 -X- _ I-Outcome
, -X- _ I-Outcome
12.6 -X- _ I-Outcome
) -X- _ I-Outcome
) -X- _ I-Outcome
. -X- _ O
CONCLUSIONS -X- _ O
: -X- _ O
The -X- _ O
increased -X- _ B-Outcome
SHAP -X- _ I-Outcome
in -X- _ I-Outcome
households -X- _ I-Outcome
of -X- _ I-Outcome
vaccinated -X- _ I-Outcome
participants -X- _ I-Outcome
who -X- _ I-Outcome
nonetheless -X- _ I-Outcome
had -X- _ I-Outcome
confirmed -X- _ I-Outcome
influenza -X- _ I-Outcome
infection -X- _ I-Outcome
supports -X- _ I-Outcome
the -X- _ I-Outcome
hypothesis -X- _ I-Outcome
that -X- _ I-Outcome
in -X- _ I-Outcome
years -X- _ I-Outcome
of -X- _ I-Outcome
vaccine -X- _ I-Outcome
mismatch -X- _ I-Outcome
, -X- _ I-Outcome
not -X- _ I-Outcome
only -X- _ I-Outcome
is -X- _ I-Outcome
influenza -X- _ I-Outcome
vaccine -X- _ I-Outcome
less -X- _ I-Outcome
protective -X- _ I-Outcome
for -X- _ I-Outcome
the -X- _ I-Outcome
vaccine -X- _ I-Outcome
recipient -X- _ I-Outcome
, -X- _ I-Outcome
but -X- _ I-Outcome
that -X- _ I-Outcome
the -X- _ I-Outcome
populationâ€™s -X- _ I-Outcome
immunity -X- _ I-Outcome
is -X- _ I-Outcome
also -X- _ I-Outcome
lower -X- _ I-Outcome
. -X- _ O

